TY - JOUR
KW - buprenorphine/naloxone
KW - Canada
KW - Fentanyl
KW - Methadone
KW - opioid agonist therapy
KW - opioid use disorder
KW - Prescription opioids
AU - Eugenia Socias
AU - Keith Ahamad
AU - Bernard Le Foll
AU - Ron Lim
AU - Julie Bruneau
AU - Benedikt Fischer
AU - Cameron Wild
AU - Evan Wood
AU - Didier Jutras-Aswad
A1 - 
AD - British Columbia Centre on Substance Use, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada; Department of Medicine, Faculty of Medicine, University of British Columbia, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada. Electronic address: esocias@cfenet.ubc.ca.; British Columbia Centre on Substance Use, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada; Department of Family Practice, Faculty of Medicine, University of British Columbia, 3rd Floor David Strangway Building, 5950 University Boulevard, Vancouver, BC V6T 1Z3, Canada.; Centre for Addiction and Mental Health, 33 Russell Street, Toronto, ON M5S 2S1, Canada; Department of Family and Community Practice, University of Toronto, 500 University Avenue, 5th floor, Toronto, ON M5G 1V7, Canada; Department of Psychiatry, University of Toronto, 250 College Street, 8th floor, Toronto, ON M5T 1R8, Canada.; Department of Medicine, Cumming School of Medicine, University of Calgary, 2500 University Drive NW, Calgary, AB T2N 1N4, Canada.; Research Center, Centre hospitalier de l'Universite de Montreal (CRCHUM), 900 Saint Denis Street, Montreal, QC H2X 0A9, Canada; Department of Family Medicine, Faculty of Medicine, Universite de Montreal, C.P. 6128, Succursale Centre-ville, Montreal, QC H3C 3J7, Canada.; Centre for Addiction and Mental Health, 33 Russell Street, Toronto, ON M5S 2S1, Canada; Department of Psychiatry, University of Toronto, 250 College Street, 8th floor, Toronto, ON M5T 1R8, Canada; Centre for Applied Research in Mental Health and Addiction, Faculty of Health Sciences, Simon Fraser University, Suite 2400, 515 W. Hastings Street, Vancouver, BC V6B 5K3, Canada.; School of Public Health, University of Alberta, 3-300 Edmonton Clinic Health Academy 11405-87 Av, Edmonton, AL T6G 1C9, Canada.; British Columbia Centre on Substance Use, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada; Department of Medicine, Faculty of Med(TRUNCATED)
BT - Contemporary clinical trials
C5 - Education & Workforce; Opioids & Substance Use
CY - United States
DO - 10.1016/j.cct.2018.04.001
JF - Contemporary clinical trials
LA - eng
M1 - Journal Article
PB - Elsevier Inc
PP - United States
PY - 2018
SN - 1559-2030; 1551-7144
SP - 21
EP - 27
EP - 
T1 - The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale
T2 - Contemporary clinical trials
TI - The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale
U1 - Education & Workforce; Opioids & Substance Use
U2 - 29627621
U3 - 10.1016/j.cct.2018.04.001
VL - 69
VO - 1559-2030; 1551-7144
Y1 - 2018
Y2 - Jun
ER -